| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.09B | — | +4.8% |
| Cost of Revenue | $370.0M | — | +3.4% |
| Gross Profit | $721.0M | — | +5.6% |
| R&D Expense | $240.0M | — | -4.8% |
| SG&A Expense | $272.0M | — | +1.9% |
| Operating Income | $209.0M | — | +27.4% |
| Pre-tax Income | $157.0M | — | -13.7% |
| Income Tax | $23.0M | — | -54.9% |
| Net Income | $134.0M | -59.9% | +2.3% |
| EPS (Basic) | $0.88 | — | +6.0% |
| EPS (Diluted) | $0.87 | — | +6.1% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $66.0M | -69.3% | -46.8% |
| Accounts Receivable | $738.0M | -13.6% | +5.6% |
| Inventory | $611.0M | +8.3% | +13.8% |
| Current Assets | $2.74B | -16.8% | +2.4% |
| Total Assets | $6.56B | -1.3% | +6.1% |
| Current Liabilities | $1.57B |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $289.0M | — | +20.4% |
| Capital Expenditures | $38.0M | — | +18.8% |
| Investing Cash Flow | -$366.0M | — | -481.0% |
| Financing Cash Flow | -$251.0M | — | -28.7% |
| Free Cash Flow | $251.0M | — | +20.7% |
| +8.8% |
| Stockholders' Equity | $2.68B | -1.7% | +13.0% |